Adaptimmune Therapeutics plc (MUN:473A)

Adaptimmune Therapeutics Revenue

In the year 2025, Adaptimmune Therapeutics had annual revenue of $5.92M USD. Adaptimmune Therapeutics had revenue of $-7.52M in the quarter ending December 31, 2025.

• Revenue: $5.92M
• Revenue Growth: -95.58%
• P/S Ratio: 1.46
• Revenue / Employee: $21.78K
• Employees: 272
• Market Cap: 7.36M EUR

Revenue Chart

Chart

Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	5.92M	-	-
Dec 31, 2024	-	-	-
Dec 31, 2023	60.28M	33.13M	122.05%
Dec 31, 2022	27.15M	21.00M	341.50%
Dec 31, 2021	6.15M	2.19M	55.36%
Dec 31, 2020	3.96M	2.84M	252.76%
Dec 31, 2019	1.12M	-58.38M	-98.11%
Dec 31, 2018	59.51M	21.67M	57.28%
Dec 31, 2017	37.83M	23.64M	166.47%
Dec 31, 2016	14.20M	5.22M	58.12%
Dec 31, 2015	8.98M	-892.00K	-9.04%
Jun 30, 2015	9.87M	9.05M	1,096.48%
Jun 30, 2014	825.00K	-	-
Jun 30, 2013	-	-	-

Data Source: Fiscal.ai Last updated: Dec 31, 2025

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 2, 2026

Data Sources Report a data error